Cite
Nonlytic Fc-fused IL-7 synergizes with Mtb32 DNA vaccine to enhance antigen-specific T cell responses in a therapeutic model of tuberculosis
MLA
Sun Hwa Ku, et al. “Nonlytic Fc-Fused IL-7 Synergizes with Mtb32 DNA Vaccine to Enhance Antigen-Specific T Cell Responses in a Therapeutic Model of Tuberculosis.” Vaccine, vol. 31, no. 27, Dec. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....38ab9c456769adef6429eb20bc7124a5&authtype=sso&custid=ns315887.
APA
Sun Hwa Ku, Dong-Hoon Choi, Seong Jeong Park, Bo Young Jeon, Young Chul Sung, So Shin Ahn, & Sang Nae Cho. (2012). Nonlytic Fc-fused IL-7 synergizes with Mtb32 DNA vaccine to enhance antigen-specific T cell responses in a therapeutic model of tuberculosis. Vaccine, 31(27).
Chicago
Sun Hwa Ku, Dong-Hoon Choi, Seong Jeong Park, Bo Young Jeon, Young Chul Sung, So Shin Ahn, and Sang Nae Cho. 2012. “Nonlytic Fc-Fused IL-7 Synergizes with Mtb32 DNA Vaccine to Enhance Antigen-Specific T Cell Responses in a Therapeutic Model of Tuberculosis.” Vaccine 31 (27). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....38ab9c456769adef6429eb20bc7124a5&authtype=sso&custid=ns315887.